Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer - Takeaways - MDSpire

Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer

  • By

  • Luyao Kang

  • Zuchen Yang

  • Yanna Ding

  • Ying Wu

  • Caixia Ma

  • Yaping Wang

  • Canyu Li

  • Bilan Li

  • Gaili Ji

  • May 29, 2026

  • 0 min

Share

  • 1

    Oxidative phosphorylation (OXPHOS) was identified as a core metabolic pathway in ovarian cancer (OC) through gene set enrichment analysis.

  • 2

    A new oxidative phosphorylation-related gene signature (OPRGS) was developed, serving as a reliable risk factor for prognosis in OC.

  • 3

    High-risk scores in OPRGS correlated with an immunosuppressive tumor microenvironment and resistance to paclitaxel in OC patients.

  • 4

    The study highlighted KIF1A as a key gene, upregulated in OC, potentially promoting cell proliferation, invasion, and migration.

  • 5

    The findings suggest that OPRGS may predict prognosis, immune infiltration, and chemotherapy sensitivity in ovarian cancer patients.

Original Source(s)

Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer

  • by Luyao Kang, Zuchen Yang, Yanna Ding, Ying Wu, Caixia Ma, Yaping Wang, Canyu Li, Bilan Li, Gaili Ji

  • May 29, 2026

Related Content

From AI-based image analysis to surgical decision support in prostate cancer: interdisciplinary application of the international radiomics platform

Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment